Educational content on VJDementia is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Ian McKeith, FMedSci, MD, FRSB, FRCPsych from Newcastle University, Newcastle, UK talks to us the importance of biomarkers in the characterization of patients suffering from dementia, and discusses a common misunderstanding about their use for this purpose. This interview was recorded at the 2017 Alzheimer’s Association International Conference (AAIC) held in London, UK.
We use cookies to provide the best experience on our website. We also use third party cookies to collect analytical data and better improve our marketing strategies. If you continue to use this site you are consenting to the use of these cookies. For more information view our Cookie Policy.